SightfileU.S. market data from official filings

MEIRAGTX HLDGS PLC (MGTX)

Name: MEIRAGTX HLDGS PLC (MGTX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001735438 · EDGAR filings · Updated 2026-07-21

MEIRAGTX HLDGS PLC (MGTX) has reported institutional ownership of 82.7%, with 133 institutional managers holding positions valued at $583.0M per the latest 13F reporting period.

Institutional ownership

82.7%

Institutional managers

133

Reported 13F value

$583.0M

Insider activity

42 trans.

−$2.05M net selling

Latest updates

2026-07-21 — Insider transaction reported (Form 4)
2026-07-21 — Notice of proposed sale filed (Form 144)
2026-07-07 — Insider transaction reported (Form 4)
2026-07-07 — Notice of proposed sale filed (Form 144)
2026-07-07 — Current report (8-K) filed
2026-06-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MEIRAGTX HLDGS PLC has 133 institutional holders and institutional ownership of 82.7%.

Insider activity

Insiders reported 42 transactions (0 buys, 7 sells) across 7 reporting insiders, with a net reported value of −$2.05M.

Related companies

XERIS BIOPHARMA HOLDINGS INC (XERS) · OMADA HEALTH INC (OMDA) · BIOAGE LABS INC (BIOA) · RELMADA THERAPEUTICS INC (RLMD) · ARVINAS INC (ARVN) · IRONWOOD PHARMACEUTICALS INC (IRWD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.